The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Novel predictors of mild paravalvular aortic regurgitation in SAPIEN 3 transcatheter aortic valve implantation
EuroIntervention 2018;14:58-68 published online February 2018. DOI: 10.4244/EIJ-D-18-00005
Gilbert H.L. Tang1*, MD, MSc, MBA; Syed Zaid2, MD; Samuel R. Schnittman3, BA; Hasan Ahmad4, MD; Ryan Kaple5, MD; Cenap Undemir6, MD; Tanya Dutta4, MD; Angelica Poniros4, RCS; Joanne Bennett6, FNP-BC; Cheng Feng7, DO; Martin Cohen4, MD; Steven L. Lansman6, MD, PhD
1. Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA; 2. Department of Medicine, Westchester Medical Center, Valhalla, NY, USA; 3. Icahn School of Medicine at Mount Sinai, New York, NY, USA; 4. Division of Cardiology, West
Aims: Paravalvular leak (PVL) remains an important issue in TAVI. The Edwards SAPIEN 3 (S3) valve has reduced PVL but in up to one third of patients mild leak remains. Our study aimed to